±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 1083  |  »Ø¸´: 1

Ãβ»Âädyn

гæ (СÓÐÃûÆø)

[ÇóÖú] ÇëÎÊ£¬ÓÐÖªµÀ±»FDAÅú×¼µÄ¿ÉÒÔÓÃÓڷβ¿¸øÒ©µÄ±íÃæ»îÐÔ¼ÁµÄÂ𣿠ÒÑÓÐ1È˲ÎÓë

ÐèÒªÕâ·½ÃæµÄÐÅÏ¢£¬µ«ÊDz»ÖªµÀÔÚÄIJéÕÒ£¬Ï£ÍûÖªµÀµÄͬ°û¿ÉÒÔÖ¸µ¼Ò»Ï£¬Íò·Ö¸Ðл£¡
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

voyager88

½ð³æ (ÖøÃûдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
Ãβ»Âädyn: ½ð±Ò+5, ¡ïÓаïÖú 2015-09-08 12:49:01
Á×Ö¬£¬ÓÍËá¶¼¿ÉÒÔʹÓã¬Ïê¼ûÎüÈë·Û¼Á£¬ÆøÎí¼ÁÐÐÒµÖ¸ÄÏ¡£µ«ÊǼ¶±ðÒªÇó½Ï¸ß£¬²»ÊÇÒ»°ãµÄÁ×Ö¬¡£ÒÔÏÂÊÇÖ¸µ¼Ô­ÔòÔ­ÎÄ£¬ÒëÎͼ¸øÄ㸽ÉÏÁË£¬ÏëÒªÕÒµ½Ô­Îļþ£¬¸´ÖÆÆäÖÐÒ»¾ä»°£¬°Ù¶È¾ÍÄܸ㶨
When Lecithin, NF, a surfactant, is used in MDI formulations, additional acceptance criteria and tests controlling the complete compositional profile should be used (e.g., levels of phosphatidyl choline, phosphatidyl ethanolamine, phosphatidyl inositol, lysophosphatidyl choline, phosphatidic acid, triglycerides, fatty acids, carbohydrates).
NFÖÐÁ×Ö¬ÊÇÒ»ÖÖ±íÃæ»îÐÔ¼Á£¬µ±ÓÃÓÚMDIsʱ£¬Ó¦Ê¹Óøü¶àµÄÑéÊÕ±ê×¼ºÍ²âÊÔÏîÄ¿£¬ÒÔ¿ØÖÆ×é·ÖÍêÕûµÄÌØÕ÷£¨Á×Ö¬õ£µ¨¼î¡¢Á×Ö¬õ£´¼°·¡¢Á×Ö¬õ£¼¡´¼¡¢ÈÜѪÁ×Ö¬õ£µ¨¼î¡¢Á×Ö¬Ëá¡¢¸ÊÓÍÈýõ¥¡¢Ö¬·¾ËáºÍ̼ˮ»¯ºÏÎïµÈµÄˮƽ£©¡£
When Oleic Acid, NF is used as a surfactant in MDI formulations, additional specifications should be included for identification, assay, and for characterization and control of the compositional profile of impurities (e.g., individual specified fatty acids, unknowns).
NFÖÐÓÍËáÓÃ×÷Ò»ÖÖ±íÃæ»îÐÔ¼Á£¬µ±ÓÃÓÚMDIsʱ£¬Ó¦½¨Á¢½øÒ»²½¼ø¶¨¡¢º¬Á¿¡¢±íÕ÷ºÍ¿ØÖÆÔÓÖÊÆ×µÈµÄÖÊÁ¿±ê×¼£¨ÈçÓÎÀëºÍÌØÊâÖ¬·¾Ëᣬδ֪Î¡£
΢ÐŹ«ÖںţºPharmaguider£¨Ò©ÊÂ×ݺᣩ£¬Ö÷Ò³£ºwww.pharmaguider.cn
2Â¥2015-09-08 11:13:06
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ Ãβ»Âädyn µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 26¿¼Ñе÷¼Á0710 0860 +9 ²¹²¹²»²¹ 2026-04-03 14/700 2026-04-04 23:32 by ¹û¶³´óÍõ
[¿¼ÑÐ] 285Çóµ÷¼Á +8 ŶßϺôo 2026-04-04 8/400 2026-04-04 23:16 by lqwchd
[¿¼ÑÐ] 315Çóµ÷¼Á +8 ÐÀϲ777 2026-04-04 9/450 2026-04-04 22:45 by ÀíÏëÔÚʵ¼ùÖ®ÖÐ
[¿¼ÑÐ] 292·Ö£¬²ÄÁÏÓ뻯¹¤£¬ÉêÇëµ÷¼Á +22 ³ÌÇçÖ® 2026-04-01 26/1300 2026-04-04 22:03 by hemengdong
[¿¼ÑÐ] Ò»Ö¾Ô¸»ª±±µçÁ¦´óѧ£¨±±¾©£©£¬²ÄÁÏ¿ÆÑ§Ó빤³Ìѧ˶265£¬Çóµ÷¼Á +11 yelck 2026-04-03 12/600 2026-04-04 19:52 by dongzh2009
[¿¼ÑÐ] »¯Ñ§308·Öµ÷¼Á +23 ÄãºÃÃ÷ÌìÄãºÃ 2026-03-30 24/1200 2026-04-04 18:29 by macy2011
[¿¼ÑÐ] 311Çóµ÷¼Á +11 Ó¸ҵÄСÎâ 2026-04-02 11/550 2026-04-03 21:46 by qlm5820
[¿¼ÑÐ] 281Çóµ÷¼Á +10 aaawhy 2026-04-03 10/500 2026-04-03 21:42 by lbsjt
[¿¼ÑÐ] 338Çóµ÷¼Á +4 zzz£¬£¬r 2026-04-03 4/200 2026-04-03 16:39 by lijunpoly
[¿¼ÑÐ] Ò»Ö¾Ô¸ÉúÎïÓëÒ½Ò©£¬296·Ö£¬Çóµ÷¼Á +8 66¹ 2026-04-03 9/450 2026-04-03 14:22 by »¯Ñ§»¯¹¤Ë¶Ê¿ÕÐÉ
[¿¼ÑÐ] 266Çóµ÷¼Á +3 08µçÆø¹¤³Ì 2026-04-03 3/150 2026-04-03 14:05 by 1753564080
[¿¼ÑÐ] ũѧ¿¼ÑÐÇóµ÷¼Á +3 dkdkxm 2026-04-01 3/150 2026-04-02 16:04 by wangjagri
[¿¼ÑÐ] 318Çóµ÷¼Á +3 óÆÐÐÖÂÔ¶. 2026-03-31 4/200 2026-04-02 15:56 by Jaylen.
[¿¼ÑÐ] 266Çóµ÷¼Á +4 ѧԱ97LZgn 2026-04-02 4/200 2026-04-02 13:03 by yulian1987
[¿¼ÑÐ] 261ÇóBÇøµ÷¼Á +5 Ã÷×С¤ 2026-04-01 7/350 2026-04-02 11:17 by ×Þξξ
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©¿Æ¼¼£¬085601×Ü·Ö305Çóµ÷¼Á +9 °ëÉú¹Ï£¡ 2026-04-01 11/550 2026-04-02 08:28 by Wang200018
[¿¼ÑÐ] 085600£¬320·ÖÇóµ÷¼Á +5 ´ó²öС×Ó 2026-04-01 6/300 2026-04-01 19:40 by ÌÆãå¶ù
[¿¼ÑÐ] µ÷¼ÁÉêÇë +8 ÕÅÕÅÕÅÕÅzy 2026-03-31 9/450 2026-04-01 08:29 by zjbkx
[¿¼ÑÐ] ±¾¿Æ211×Ü·Ö289£¬08¹¤Ñ§ÕæÐÄÇóµ÷¼Á +3 utopiaE 2026-03-30 3/150 2026-03-30 23:42 by ms629
[¿¼ÑÐ] 11408×Ü·Ö309£¬Ò»Ö¾Ô¸¶«ÄÏ´óѧÇóµ÷¼Á£¬²»Ìôרҵ +5 Ì츳´øµ½THU 2026-03-29 6/300 2026-03-30 20:49 by dick_runner
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û